Published in Z Kardiol on May 01, 1987
Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats. Br J Pharmacol (2003) 0.77
The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent. Br J Pharmacol (1990) 0.75
Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (2000) 2.71
Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol (2001) 2.08
[Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris]. Dtsch Med Wochenschr (1999) 2.05
Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur Respir J (1995) 2.00
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
Fetal tachyarrhythmias: transplacental and direct treatment of the fetus-a report of 60 cases. Ultrasound Obstet Gynecol (1991) 1.63
Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study. Eur Heart J (2000) 1.62
Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation (1999) 1.57
[Löffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia]. Z Kardiol (1998) 1.50
Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol (2001) 1.49
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. Dtsch Med Wochenschr (2001) 1.44
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Automatic implantable cardioverter/defibrillator (AICD) and antitachycardia pacemaker (Tachylog): combined use in ventricular tachyarrhythmias. Pacing Clin Electrophysiol (1986) 1.42
Dose and rate-dependent effects of adenosine on atrial action potential duration in humans. J Interv Card Electrophysiol (1997) 1.41
[Biventricular thrombi dissolution and antibody development with lepirudin therapy]. Dtsch Med Wochenschr (2003) 1.40
Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation (1992) 1.39
[Atrial fibrillation: a frequent problem in clinical practice]. Dtsch Med Wochenschr (1998) 1.38
Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol (1997) 1.32
Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J (1998) 1.29
Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am J Cardiol (1999) 1.29
Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology (1999) 1.24
Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res (1999) 1.20
Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol (1993) 1.13
Color-coded Doppler imaging of the vena contracta as a basis for quantification of pure mitral regurgitation. Am J Cardiol (1994) 1.07
Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J (1994) 1.06
Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems. Pacing Clin Electrophysiol (1995) 1.05
[Influence of insulin on membrane potentials in potassium deficiency measurements in isolated rat diaphragm]. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 1.04
Multiplane transesophageal echocardiographic assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Am J Cardiol (1994) 1.02
Transverse conduction capabilities of the crista terminalis in patients with atrial flutter and atrial fibrillation. J Am Coll Cardiol (1999) 1.02
Predictive diagnostic value of clinical assessment and nonlaboratory monitoring system recordings in patients with symptoms suggestive of obstructive sleep apnea syndrome. Respiration (1997) 1.02
Imaging of thrombi and assessment of left atrial appendage function: a prospective study comparing transthoracic and transoesophageal echocardiography. Heart (1999) 1.01
Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet (1997) 1.00
Acute and long-term effects of consecutive radiofrequency applications on conduction properties of the subeustachian isthmus in type I atrial flutter. J Cardiovasc Electrophysiol (1998) 0.99
Quality of life in patients with silent atrial fibrillation. Heart (2001) 0.99
Evolution of insular Pacific Pittosporum (Pittosporaceae): origin of the Hawaiian radiation. Mol Phylogenet Evol (2002) 0.99
Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med (1998) 0.98
Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J (1995) 0.97
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol (1999) 0.97
Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther Drug Monit (2001) 0.96
Incidence of left atrial thrombi in patients in sinus rhythm and with a recent neurologic deficit. Am Heart J (2000) 0.94
Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol (1998) 0.94
Fate of POPs (DDX, HCHs, PCBs) in upper soil layers of pine forests. Sci Total Environ (2002) 0.92
Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J (1997) 0.91
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins. Heart (2005) 0.91
Verification of linear lesions using a noncontact multielectrode array catheter versus conventional contact mapping techniques. J Cardiovasc Electrophysiol (1999) 0.91
Prospective evaluation of shoulder-related problems in patients with pectoral cardioverter-defibrillator implantation. Am Heart J (1998) 0.90
Influence of obstructive sleep apnea on heart rate turbulence. Basic Res Cardiol (2005) 0.90
Fatal invasive pulmonary aspergillosis associated with adalimumab therapy. Gut (2009) 0.90
[Atrial fibrillation: rate or rhythm control--individual patient management]. Z Kardiol (2005) 0.89
Epicardial neodymium. YAG laser photocoagulation of ventricular tachycardia without ventriculotomy in patients after myocardial infarction. Circulation (1996) 0.89
[The value of magnesium in intensive care medicine]. Z Kardiol (1994) 0.88
Atrial fibrillation - patients at high risk for cerebral embolism. Clin Res Cardiol (2006) 0.88
Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol (1998) 0.88
Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms. Z Kardiol (2005) 0.87
[History of atrial fibrillation]. Z Kardiol (2003) 0.87
Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol (1995) 0.87
Radiofrequency catheter ablation of symptomatic ventricular ectopic beats originating in the right outflow tract. Pacing Clin Electrophysiol (1999) 0.87
Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein. Heart (2005) 0.87
NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol (2006) 0.87
Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J (1994) 0.87
Heart rate variability in patients with sleep-related breathing disorders. Cardiology (1997) 0.86
Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol (1998) 0.86
Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. Eur Heart J (1992) 0.86
Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol (1992) 0.85
A comparison of captopril and digoxin in the treatment of patients with mild-to-moderate chronic congestive heart failure. Clin Ther (1995) 0.85
Blood flow assessment by ultrasound-induced destruction of echocontrast agents using harmonic power Doppler imaging: which parameters determine contrast replenishment curves? Echocardiography (2001) 0.85
Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV). J Cardiovasc Pharmacol (1989) 0.84
Left atrial appendage function in patients with atrial flutter. Heart (1997) 0.84
[Hemodynamics, left ventricular volumes and compliance in 167 patients with congenital and acquired heart disease (author's transl)]. Klin Wochenschr (1975) 0.84
[Atrial fibrillation -- interventional therapy with respect to age]. Dtsch Med Wochenschr (2005) 0.84
Are microbubbles free flowing tracers through the Myocardium? Comparison of indicator-dilution curves obtained from dye dilution and echo contrast using harmonic power Doppler imaging. Echocardiography (2000) 0.84
The "low intensity treadmill exercise" protocol for appropriate rate adaptive programming of minute ventilation controlled pacemakers. Pacing Clin Electrophysiol (1995) 0.83
European policy on driving for patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1996) 0.83
[Membrane potentials in experimental potassium deficiency. Measurements in rat diaphragm in vitro]. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 0.83
Electrophysiologic effects of dextro- and levo-verapamil on sinus node and AV node function in humans. J Cardiovasc Pharmacol (1988) 0.83
The (Na + + K + )-ATPase activity of guinea pig heart muscle in potassium deficiency. Arch Biochem Biophys (1971) 0.83
Transcatheter PFO closure with a prominent Eustachian valve. Z Kardiol (2004) 0.82
Predictors of success in radiofrequency catheter ablation of atrial flutter. J Interv Card Electrophysiol (2000) 0.82
Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease. Z Kardiol (2003) 0.82
[Effect of glucagon on extracellular potassium concentration measurements in aorta, hepatic vein and coronary sinus in man]. Klin Wochenschr (1971) 0.82
Economic upheaval in 1990-93 and the ecological situation in central Germany. Environ Pollut (1999) 0.82
Transcatheter closure of a posttraumatic ventricular septal defect with an Amplatzer occluder device. Catheter Cardiovasc Interv (2001) 0.82
Chronic sulfur dioxide exposure in a smelter. I. Exposure to SO2 and dust: 1940-1974. J Occup Med (1978) 0.82
Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration (1996) 0.82
[Junctional arrhythmias in radiofrequency modification of the atrioventricular node]. Z Kardiol (1995) 0.82
Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia. Infection (1996) 0.82
Impact of the local atrial electrogram in AV nodal reentrant tachycardia: ablation versus modification of the slow pathway. J Cardiovasc Electrophysiol (1995) 0.81
[Value and risk of programmed ventricular stimulation in patients with chronic recurrent ventricular tachycardia (author's transl)]. Klin Wochenschr (1981) 0.81
Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls. Stroke (1997) 0.81